VitaDX will be present at EAU24
3 April 2024 -
VitaDX selected by Pfizer and WILCO to be part of the new #PfizerHealthcareHub France promo
16 January 2024 -
Avero Diagnostics and VitaDX announce the signing of a strategic partnership for the distribution in the United States of VisioCyt® Bladder, a diagnostic test for bladder cancer
18 December 2023 -
CFU et Carrefour Pathologie
VitaDX at CFU and Carrefour Pathologie!
17 November 2023 -
Launch of the participatory financing campaign!
14 November 2023 -

It's official: the Sowefund crowdfunding campaign is now public and open to all!

VitaDX wins France2030's "Medical Imaging" call for projects!
18 October 2023 -
JT 20h TF1
VisioCyt® on TF1!
8 June 2023 -

A big thank you to the TF1 Group for this report broadcast on June 07, 2023 on the 8:00 pm news, showing the benefits of Artificial Intelligence…

Come and meet us !
2 January 2023 -

We will be present at several events in 2023. If you'd like to find out more about us and VisioCyt, our first innovative…

Mltidisciplinary Masterclass dedicated to prostate and bladder cancers
8 July 2022 -

Multidisciplinary Masterclass organized by the American Hospital in Paris, MEDIPATH and Ibex Medical Analytics dedicated to prostate and bladder…